Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Abbott Laboratories (NYSE:ABT)

During the Trading Day
45.46 +0.54 / +1.20%
As of 4:01pm ET
Day’s Change
During After-Hours   Switch to standard view »
45.46 0.00 / 0.00%
Volume: 77.4K

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Quarter 4
Quarter 1
Quarter 2
Quarter 3
Operating ActivitiesNet Income / Starting Line904.0M2.3B784.0M580.0M
Total Other Cash Flow125.0M-2.7B-149.0M27.0M
Funds From Operations1.4B-10.0M987.0M990.0M
Funds From/For Other Operating Expenses186.0M-12.0M46.0M-205.0M
Net Cash Flow - Operating Activities1.2B2.0M941.0M1.2B
InvestingIncrease In Investments-1.5B-213.0M-1.8B-570.0M
Decrease In Investments2.3B------
Capital Expenditures-287.0M-235.0M-216.0M-411.0M
Fixed Asset Disposal--230.0M2.3B0.00
Net Assets From Acquisitions -495.0M-----231.0M
Other Investing - Sources13.0M13.0M15.0M15.0M
Net Cash Flow Investing-10.0M-205.0M242.0M-1.2B
FinancingShort Term Borrowings74.0M-1.5B-47.0M-501.0M
Long Term Borrowings0.002.5B0.000.00
Long Term Debt Reduction-577.0M-10.0M-23.0M-3.0M
Net Proceeds Stock Sale139.0M156.0M57.0M50.0M
Common Preferred Redeemed-1.0M-1.3B-1.0M-2.0M
Common Dividends----------
Cash Dividends Paid - Total-335.0M-364.0M-360.0M-359.0M
Other Sources - Financing0.
Other Uses - Financing0.
Net Cash Flow - Financing-700.0M-550.0M-374.0M-815.0M
Exchange RateEffect of Exchange Rate on Cash-78.0M-84.0M13.0M-99.0M
Net Change In Cash528.0M-753.0M809.0M-817.0M